<DOC>
	<DOCNO>NCT00200434</DOCNO>
	<brief_summary>The purpose study contrast efficacy safety 3 dose level nebivolol vs. placebo , add patient 's exist antihypertensive medication ( ) 3 month , patient mild moderate hypertension</brief_summary>
	<brief_title>A Study Efficacy Safety Nebivolol Added Existing Antihypertensive Treatment Patients With Hypertension</brief_title>
	<detailed_description>Following washout previous beta-blocker medication , applicable , supine , sit , stand cuff blood pressure pulse rate , 24-hour ambulatory blood pressure monitoring ( ABPM ) , ECG , laboratory assessment genomics test performed randomization . Patients randomize receive placebo nebivolol daily morning together curently prescribe antihypertensive therapy . Patients four scheduled clinical visit study , follow screen visit .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>Average sit diastolic blood pressure ( DBP ) great equal 90 mmHg less equal 109 mmHg screen baseline , patient background antihypertensive therapy take least one two either ACE inhibitor , ARB , diuretic . Recent myocardial infarction stroke Contraindications betablocker therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Nebivolol</keyword>
	<keyword>Beta-Blocker</keyword>
	<keyword>Hypertension</keyword>
</DOC>